Trying to separate three different claims about oxandrolone: that it is the right molecule, that it is the right dose, and that it does something useful.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
What the anabolic class does pharmacologically does not require the subjective effect to be large to be real.
The last two weeks of a cycle and the first month after it are where most people feel worst.
Willing to accept that my own experience is the weakest evidence in the room.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Nobody has ever been talked out of a stack by a stranger on the internet.
What is the first thing you would read if you were starting from zero?
Same here.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid. Not on oxandrolone but the pattern is familiar.
Narrow conclusion.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Most of what is called evidence here is one person, one vial, one month.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial. Two years in on oxandrolone and it lines up.
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all?